-
Beijing University of Chinese Medicine collaborates with Elsevier to launch first branch of traditional Chinese medicine taxonomy
Mar 4, 2020, 12:21 PM by Michael CroftNEW YORK, NY, UNITED STATES - Mar 4, 2020 - Elsevier, a global leader in information analytics, specializing in science and health, launched the first branch of its Traditional Chinese Medicine (TCM) taxonomy in collaboration with Beijing University of Chinese Medicine (BUCM), a leader in the field of TCM research and medical treatmentFull story -
Signant Health Appoints Ian Jennings as Chief Commercial Officer
Mar 4, 2020, 09:32 AM by Michael CroftPHILADELPHIA, PA - Mar 4, 2020 - Ian brings 30 years of commercial technology experience in the life sciences industry, with a proven track record of developing and leading successful sales and marketing teams in clinical and healthcare innovationFull story -
Liu Named 2020 Benjamin Franklin Award Laureate
Mar 3, 2020, 13:00 PM by Michael CroftFull storyBio-IT World | The Dana-Farber Cancer Institute and Harvard School of Public Health’s Xiaole Shirley Liu has been named the 2020 Benjamin Franklin Award Laureate, Bioinformatics.org announced today.
-
New Multiplex mode for ZEISS Airyscan 2 enables fast and gentle confocal microscopy
Mar 3, 2020, 12:15 PM by Michael CroftJENA, GERMANY - Mar 3, 2020 - The new Multiplex mode for ZEISS Airyscan 2 delivers more information in less time. Smart illumination and detection schemes allow parallel pixel acquisition for fast and gentle confocal microscopyFull story -
MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020
Mar 3, 2020, 10:12 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Mar 3, 2020 - MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI (with PET or SPECT) and new benchtop PET/CT systems to the imaging science community at the 15th European Molecular Imaging Meeting (EMIM 2020) on March 24 – 27, 2020 in Thessaloniki, GreeceFull story -
WCG CenterWatch iConnect Selected as Patient Recruitment Management System for The Michael J. Fox Foundation’s Clinical Study Matching Tool, Fox Trial Finder
Mar 3, 2020, 09:15 AM by Michael CroftPRINCETON, NJ - Mar 3, 2020 - WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced that The Michael JFull story -
BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations
Mar 3, 2020, 08:13 AM by Michael CroftWESTBURY, NY - Mar 3, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, announced that it is now providing same-day delivery of fresh blood, LEUKOMAX® leukopaks and buffy coats from normal and disease-state donors to cell and gene therapy researchers in the UKFull story -
COVID-19 could be identified in minutes via mobile technology
Mar 2, 2020, 14:04 PM by Michael CroftAUCKLAND, NEW ZEALAND - Mar 3, 2020 - Fast testing during viral outbreaks, such as the current COVID-19, could assist to prevent its spread, saving lives and moneyFull story -
Hints On Data Storage And Transport From High Energy Physics
Mar 2, 2020, 14:00 PM by Michael CroftFull storyBio-IT World | It may be surprising that with a PhD in biochemistry, Brigitte Raumann spends a lot of time these days considering data storage and transport in high energy physics and astronomy. But that also puts her in the perfect position to recognize some of the lessons from those disciplines that the life sciences can pick up.
-
Olaris Announces Findings from Exploratory Analysis of Biomarkers that Predict Patient Responsiveness to Trastuzumab Therapy
Mar 2, 2020, 08:36 AM by Michael CroftWALTHAM, MA, UNITED STATES - Mar 2, 2020 - Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced the findings from its exploratory analysis of biomarkers of response (BoR) that predict whether a HER2-positive (Her2+) metastatic breast cancer patient will respond to Herceptin® (trastuzumab) therapyFull story -
Solentim names Mark Truesdale as new CEO
Mar 2, 2020, 04:52 AM by Michael CroftBOURNEMOUTH, UK - Mar 2, 2020 - Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed to the position of CEOFull story -
Legit™ Unveils A New Collaboration Software For Life Sciences
Feb 28, 2020, 09:55 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Feb 28, 2020 - Legit, the leading life sciences collaboration platform, announced today the launch of their new collaboration software geared towards the life sciencesFull story -
Alfa Chemistry Introduced Functionalized Nanomaterials
Feb 27, 2020, 22:16 PM by Michael CroftNEW YORK, NY - Feb 28, 2020 - On February 20, 2020, Alfa Chemistry announced to introduce a wide range of functionalized nanomaterials to meet the increasing demand from their global customersFull story -
MGI Announces $100 Genome; Illumina Files Patent Suit
Feb 27, 2020, 18:25 PM by Michael CroftBio-IT World MGI got some attention with its presentation this week of the $100 genome. Among the feedback, a patent infringement suit from Illumina relating to the “CoolMPS” sequencing products.Full story -
Menarini Silicon Biosystems To Announce New Solutions for Advancing Liquid Biopsy in Clinical Research
Feb 27, 2020, 12:32 PM by Michael CroftBOLOGNA, ITALY AND HUNTINGDON VALLEY, PA - Feb 27, 2020 - Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help advance precision medicine research by expanding the capabilities and applications of its CELLSEARCH and DEPArray technologies, for rare cells isolation and single cell analysisFull story -
Illumina, NSA Labs, Certara, And More: News From February 2020
Feb 27, 2020, 10:10 AM by Michael CroftFull storyBio-IT World February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Illumina, NSA Labs, Certara, and more.
-
Bio Filters For Air Pollution Control Outlook, Product, Industry Developments and Opportunities
Feb 27, 2020, 04:15 AM by Michael CroftALBANY, NY, US - Feb 27, 2020 - Transparency Market Research delivers key insights on the global bio filter market. In terms of revenue, the global bio filter market is estimated to expand at a CAGR of ~7%, based on value, during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the global bio filter market reportFull story -
The Pistoia Alliance’s Releases Latest Unified Data Model
Feb 26, 2020, 14:00 PM by Michael CroftBio-IT World The Pistoia Alliance yesterday released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS). V6 delivers a stable foundation for the collection and exchange of reaction data and empowers the community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. As increased adoption of AI and ML in R&D continues, such industry-wide data standards are essential in the move toward the digitally driven Lab of the Future (LoTF).Full story -
A Deep Look At The Future Of Medicine
Feb 26, 2020, 13:00 PM by Michael CroftBio-IT World Cardiologist Eric Topol, author of the Creative Destruction of Medicine and The Patient Will See You Now has often written about medicine and technology. But Deep Medicine isn’t just about technology.Full story -
Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China
Feb 25, 2020, 17:16 PM by Michael CroftSAN FRANCISCO BAY AREA, CA, US - Feb 25, 2020 - Paris, February 25, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang[1], in China, to help them better detect the coronavirus and monitor its mutationsFull story